Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
|
AU |
|
Associated Capital Group Inc
F:41J
|
US |
|
General Electric Co
NYSE:GE
|
US |
|
Amadeus IT Group SA
OTC:AMADF
|
ES |
|
Enensys Technologies SA
F:20U
|
FR |
|
M
|
Many Peaks Minerals Ltd
ASX:MPK
|
AU |
|
V
|
Verizon Communications Inc
F:BAC
|
US |
|
V
|
Valmet Corp
F:2VO
|
FI |
|
Shanghai Electric Group Co Ltd
SSE:601727
|
CN |
|
M
|
Matsui Securities Co Ltd
XMUN:MTW
|
JP |
|
H
|
Henry Schein Inc
DUS:HS2
|
US |
|
Focus Minerals Ltd
OTC:FCSUF
|
AU |
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
Monash IVF Group Ltd
ASX:MVF
|
AU |
Intrinsic Value
Is CLVLF undervalued or overvalued?
See the intrinsic value estimate for 
Clinuvel Pharmaceuticals Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CLVLF looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CLVLF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Clinuvel Pharmaceuticals Does
Clinuvel Pharmaceuticals is a specialty drug company that makes treatments for rare skin and light-sensitivity disorders. Its best-known product is SCENESSE, a prescription medicine used to help people with erythropoietic protoporphyria, a condition that can make sunlight exposure painful and difficult to manage. The company also works on other therapies linked to skin protection and pigmentation.
- Headquarters
- Australia AU
- Employees
- 16
- IPO date
- Feb 13, 2001
Earnings Waterfall
Clinuvel Pharmaceuticals Ltd
The intrinsic value for Clinuvel Pharmaceuticals Ltd (CLVLF) under the Base Case is hidden USD.
Compared with the current market price of 5.05 USD, the stock appears hidden.